通过向性酸性中介传递抗原MHC结合
Joey J Kelly1, Emily T Ankrom2, Sarah E Newkirk1
1Department of Chemistry, University of Virginia, Charlottesville, VA, United States.
Frontiers in immunology
|April 26, 2024
概括
研究人员使用低pH插入 (pHLIP) 来向癌细胞输送抗原. 这种方法增强T细胞激活,改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药物运输 药物运输 药物运输
背景情况:
- 细胞毒性T淋巴细胞对于抗癌免疫是至关重要的,在瘤细胞上识别-MHC复合体.
- 向-MHC复合体 (pMHC) 是一个有前途的癌症免疫治疗策略.
- 酸性瘤微环境为选择性药物输送提供了一个独特的目标.
研究的目的:
- 调查低pH插入 (pHLIP) 的使用,以向向癌细胞输送抗原.
- 评估交付的在MHC复合体上的表现和随后的T细胞激活.
- 探索pHLIP作为一种增强抗癌免疫疗法的工具的潜力.
主要方法:
- 利用酸性瘤微环境触发pHLIP介导的交付.
- 将MHC结合直接输送到黑色素瘤细胞的细胞质中.
- 评估MHC分子上抗原的呈现.
- 测量对MHC呈现的反应中的T细胞激活.
主要成果:
- 成功地将抗原送入黑色素瘤细胞的细胞质中.
- 在癌细胞表面的MHC复合体上演示了交付的呈现.
- 在呈现抗原时观察到T细胞的激活.
- 验证了pHLIP在向癌细胞和启动免疫反应方面的有效性.
结论:
- pHLIP 作为一种有效的载体,可以将抗原向癌细胞提供.
- 这种方法通过MHC复合体促进抗原的呈现,激活T细胞.
- 通过pHLIP介导的分娩具有显著的潜力,可以增强抗癌免疫疗法策略.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
9.8K
相关概念视频
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K
Antigens Involved in Adaptive Immunity
487
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
487
